Literature DB >> 170071

Specific prolactin binding sites in the prostate and testis of rats.

C Aragona, H G Friesen.   

Abstract

Specific binding sites for prolactin have been detected in membrane preparations from the testis, epididymis, seminal vesicles and prostate of male rats. The binding was time and temperature dependent. In prostatic tissue the binding of prolactin was a saturable process with an association constant (Ka) of 3 X 10(9) M-1 and a binding capacity of 125 femtomoles per mg of protein. The binding of prolactin to the prostate was inhibited only by lactogenic hormones. In the testis the low binding of prolactin increased slightly from 20 to 70 days of age. On the other hand, in the prostate the highest specific binding was found in membrane preparation from 20-day-old rats while 270-day-old rats had only 10% as much specific binding. The administration of estrogen also lowered prolactin binding to prostatic membranes. Castration caused an even greater decrease in the binding of [125I] iodo PRL in the prostate whereas in the liver this procedure resulted in a major increase in the binding of labeled prolactin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170071     DOI: 10.1210/endo-97-3-677

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Effects of metoclopramide on mRNA levels of steroid 5α-reductase isozymes in prostate of adult rats.

Authors:  Pilar Sánchez; Jesús M Torres; Beatriz Castro; José F Frías; Esperanza Ortega
Journal:  J Physiol Biochem       Date:  2012-07-18       Impact factor: 4.158

2.  Immunocytochemical detection of prolactin or prolactin-like immunoreactivity in epididymis of mature male mouse.

Authors:  W B Brumlow; C S Adams
Journal:  Histochemistry       Date:  1990

3.  Anti-growth action on mouse mammary and prostate glands of a monoclonal antibody to prolactin receptor.

Authors:  J F Sissom; M L Eigenbrodt; J C Porter
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

4.  Treatment of advanced prostatic cancer with anti-androgens alone and a combination of anti-androgen with anti-prolactin--a pilot study.

Authors:  E Hoogendijk; H J de Voogt
Journal:  Urol Res       Date:  1986

5.  Effect of prolactin and the anit-prolactin bromocriptin on the testosterone uptake and metabolism in androgen-sensitive and insensitive canine organs.

Authors:  D Helmerich; J E Altwein
Journal:  Urol Res       Date:  1976-11-10

6.  Interaction of cell-membrane prolactin receptor with its antibody.

Authors:  R P Shiu; H G Friesen
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

7.  Total prolactin binding sites in human breast cancer biopsies.

Authors:  J P Peyrat; D Dewailly; J Djiane; P A Kelly; B Vandewalle; J Bonneterre; J Lefebvre
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

8.  Radioautographic identification of lactogen binding sites in rat median eminence using 125I-human growth hormone: evidence for a prolactin "short-loop" feedback site.

Authors:  M van Houten; B I Posner; R J Walsh
Journal:  Exp Brain Res       Date:  1980       Impact factor: 1.972

9.  Histoimmunological identification of a prolactin-like substance in rodent testis.

Authors:  M Roux; N Martinat; J P Richoux; G Grignon
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

10.  Effects of sulpiride induced hyperprolactinemia on testosterone secretion and metabolism before and after HCG in normal men.

Authors:  G P Bernini; M Gasperi; F Franchi; M Luisi
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.